These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Modulation of renal disease in MRL/lpr mice by pharmacologic inhibition of inducible nitric oxide synthase. Reilly CM; Farrelly LW; Viti D; Redmond ST; Hutchison F; Ruiz P; Manning P; Connor J; Gilkeson GS Kidney Int; 2002 Mar; 61(3):839-46. PubMed ID: 11849435 [TBL] [Abstract][Full Text] [Related]
6. Linomide administration to mice attenuates the induction of nitric oxide synthase elicited by lipopolysaccharide-activated macrophages and prevents nephritis in MRL/Mp-lpr/lpr mice. Hortelano S; Díaz-Guerra MJ; Gonzalez-García A; Leonardo E; Gamallo C; Boscá L; Martínez-A C J Immunol; 1997 Feb; 158(3):1402-8. PubMed ID: 9013985 [TBL] [Abstract][Full Text] [Related]
7. The role of interleukin 12 and nitric oxide in the development of spontaneous autoimmune disease in MRL/MP-lpr/lpr mice. Huang FP; Feng GJ; Lindop G; Stott DI; Liew FY J Exp Med; 1996 Apr; 183(4):1447-59. PubMed ID: 8666903 [TBL] [Abstract][Full Text] [Related]
9. Effect of mycophenolate mofetil on severity of nephritis and nitric oxide production in lupus-prone MRL/lpr mice. Lui SL; Tsang R; Wong D; Chan KW; Chan TM; Fung PC; Lai KN Lupus; 2002; 11(7):411-8. PubMed ID: 12195781 [TBL] [Abstract][Full Text] [Related]